{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:14:33Z","timestamp":1790511273664,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001827","name":"Universiteit van Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001833","name":"Vrije Universiteit Amsterdam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010382","name":"European Society of Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bone.2017.10.011","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T05:46:19Z","timestamp":1507873579000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-7096","authenticated-orcid":false,"given":"Kerensa M.","family":"Beekman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0277-2533","authenticated-orcid":false,"given":"Annegreet G.","family":"Veldhuis-Vlug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania M.","family":"Oleksik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-4459","authenticated-orcid":false,"given":"Michael W.","family":"Tanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Bisschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Bravenboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.10.011_bb0005","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.2413051858","article-title":"Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation","volume":"241","author":"Griffith","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2017.10.011_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1011513223894","article-title":"Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis","volume":"2","author":"Justesen","year":"2001","journal-title":"Biogerontology"},{"key":"10.1016\/j.bone.2017.10.011_bb0015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","article-title":"Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies","volume":"80","author":"Meunier","year":"1971","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.bone.2017.10.011_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1148\/radiology.217.2.r00nv20527","article-title":"Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry","volume":"217","author":"Wehrli","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2017.10.011_bb0025","first-page":"1620","article-title":"Potential value of vertebral proton MR spectroscopy in determining bone weakness., AJNR","volume":"22","author":"Schellinger","year":"2001","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.bone.2017.10.011_bb0030","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1210\/jc.2012-3949","article-title":"Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults","volume":"98","author":"Schwartz","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.10.011_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bone.2017.10.011_bb0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1582-4934.2009.00751.x","article-title":"Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro","volume":"14","author":"Elbaz","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bone.2017.10.011_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S8756-3282(00)00252-0","article-title":"Influence of mature adipocytes on osteoblast proliferation in human primary cocultures","volume":"26","author":"Maurin","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S8756-3282(02)00805-0","article-title":"Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation","volume":"31","author":"Maurin","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1138\/20100435","article-title":"Osteoporosis as a Lipotoxic disease","volume":"7","author":"Ng","year":"2010","journal-title":"IBMS BoneKey"},{"key":"10.1016\/j.bone.2017.10.011_bb0060","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/endo.139.4.5915","article-title":"Murine bone marrow stromally derived BMS2 adipocytes support differentiation and function of osteoclast-like cells in vitro","volume":"139","author":"Kelly","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2017.10.011_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s002230001203","article-title":"Effects of a beta 3 adrenergic receptor agonist on bone and bone marrow adipocytes in the tibia and lumbar spine of the ovariectomized rat","volume":"68","author":"Kurabayashi","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.10.011_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/8756-3282(91)90011-7","article-title":"Relationships between marrow fat and bone turnover in ovariectomized and intact rats","volume":"12","author":"Martin","year":"1991","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0075","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1210\/jc.2012-1477","article-title":"Increased marrow adiposity in premenopausal women with idiopathic osteoporosis","volume":"97","author":"Cohen","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.10.011_bb0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/8756-3282(85)90327-8","article-title":"Bone marrow and bone remodeling","volume":"6","author":"Lips","year":"1985","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-008-0574-6","article-title":"Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women","volume":"19","author":"Syed","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.10.011_bb0090","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","article-title":"The use of estrogens and progestins and the risk of breast cancer in postmenopausal women","volume":"332","author":"Colditz","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.10.011_bb0095","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women","volume":"117","author":"Grady","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2017.10.011_bb0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple outcomes of Raloxifene evaluation (MORE) investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2017.10.011_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.03.033","article-title":"Raloxifene promotes adipocyte differentiation of 3T3-L1 cells","volume":"538","author":"Murase","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bone.2017.10.011_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF03347039","article-title":"The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow","volume":"34","author":"Somjen","year":"2011","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.bone.2017.10.011_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women","volume":"17","author":"Ott","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.011_bb0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bone.2017.10.011_bb0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2017.03.051","article-title":"Open source software for semi-automated histomorphometry of bone resorption and formation parameters","volume":"99","author":"van't Hof","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.10.011_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.exger.2003.11.008","article-title":"1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P\/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2)","volume":"39","author":"Duque","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bone.2017.10.011_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1522-2586(200102)13:2<263::AID-JMRI1038>3.0.CO;2-M","article-title":"Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow","volume":"13","author":"Kugel","year":"2001","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bone.2017.10.011_bb0145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jmri.23619","article-title":"Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects","volume":"36","author":"Griffith","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.bone.2017.10.011_bb0150","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators \u2013 mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.10.011_bb0155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1010019410881","article-title":"Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulator","volume":"2","author":"Bryant","year":"2001","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bone.2017.10.011_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/OGX.0b013e31828baef9","article-title":"Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications","volume":"68","author":"Gizzo","year":"2013","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.bone.2017.10.011_bb0165","first-page":"1","article-title":"Meeting report of the 2016 bone marrow adiposity meeting","volume":"0","author":"van der Eerden","year":"2017","journal-title":"Adipocytes"},{"key":"10.1016\/j.bone.2017.10.011_bb0170","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bone.2015.11.013","article-title":"New insights into bone marrow adipocytes: report from the first European meeting on bone marrow adiposity (BMA 2015)","volume":"93","author":"Hardouin","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.10.011_bb0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cmet.2017.01.001","article-title":"Parathyroid hormone directs bone marrow Mesenchymal cell fate","volume":"25","author":"Fan","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2017.10.011_bb0180","doi-asserted-by":"crossref","first-page":"16699","DOI":"10.1074\/jbc.M114.547919","article-title":"Age-related marrow adipogenesis is linked to increased expression of RANKL","volume":"289","author":"Takeshita","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.10.011_bb0185","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between adipocyte size and adipokine expression and secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2017.10.011_bb0190","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","article-title":"Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment","volume":"129","author":"Shafat","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bone.2017.10.011_bb0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02556831","article-title":"Inter-observer and intra-observer variation in bone histomorphometry","volume":"38","author":"Compston","year":"1986","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2017.10.011_bb0200","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-010-1353-8","article-title":"Effects of risedronate on bone marrow adipocytes in postmenopausal women","volume":"22","author":"Duque","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.10.011_bb0205","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2013-1172","article-title":"Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study","volume":"98","author":"Cohen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:39:20Z","timestamp":1762659560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217303770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":41,"alternative-id":["S8756328217303770"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.10.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}